Prolonged release formulations comprising an 2 -oxo1 -pyrrolidine derivative

Details for Australian Patent Application No. 2009317280 (hide)

Owner UCB Pharma, S.A.

Inventors Fanara, Domenico; Eeckman, Frederic; Berwaer, Monique

Agent Watermark

Pub. Number AU-A-2009317280

PCT Pub. Number WO2010/057870

Priority 08105817.4 18.11.08 EP; 09100312.9 02.06.09 EP

Filing date 17 November 2009

Wipo publication date 27 May 2010

International Classifications

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/057870 Priority application(s): WO2010/057870

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009317284-Process for preparing secondary amides by carbonylation of a corresponding tertiary amine

2009317279-Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate